Last update June 15, 2022
Compatible
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
C21H21ClN4OS is Ziprasidone in Molecular formula.
Is written in other languages:C21H21ClN4OS is also known as
C21H21ClN4OS belongs to these groups or families:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
An atypical or second generation antipsychotic indicated in the treatment of schizophrenia and manic episodes of bipolar disorder. Oral administration in two daily doses.
It is excreted in breast milk in trace or undetectable amounts. (Schlotterbeck 2009)
No problems were seen in a 6-month-old infant whose mother took ziprasidone during pregnancy and lactation. (Werremeyer 2009)
It can cause hyperprolactinemia and galactorrhoea. (Raza 2010. Saldaña 2007, Ramadan 2005, Kopecek 2005, Jordan 2003)
Expert authors consider this medication possible with caution during breastfeeding. (Hale, Uguz 2021), although other alternatives, such as olanzapine or quetiapine, may be preferable. (Hale, LactMed, Klinger 2013)
See below the information of this related product: